Bevacizumab in Treating Patients With Myelodysplastic Syndrome

NCT00022048 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

BIOLOGICAL: bevacizumab

Sponsor

Stanford University

Collaborators

[object Object]